The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Advantages and Limitations of Bacteriophages for the Treatment of Bacterial Infections
Open accessAbstract
Bacteriophages (BPs) are viruses that can infect and kill bacteria without any negative effect on human or animal cells. For this reason, it is supposed that they can be used, alone or in combination with antibiotics, to treat bacterial infections. In this narrative review, the advantages and limitations of BPs for use in humans will be discussed. PubMed was used to search for all of the studies published from January 2008 to December 2018 using the key words: "BPs" or "phages" and "bacterial infection" or "antibiotic" or "infectious diseases." More than 100 articles were found, but only those published in English or providing evidence-based data were included in the evaluation. Literature review showed that the rapid rise of multi-drug-resistant bacteria worldwide coupled with a decline in the development and production of novel antibacterial agents have led scientists to consider BPs for treatment of bacterial infection. Use of BPs to overcome the problem of increasing bacterial resistance to antibiotics is attractive, and some research data seem to indicate that it might be a rational measure. However, present knowledge seems insufficient to allow the use of BPs for this purpose. To date, the problem of how to prepare the formulations for clinical use and how to avoid or limit the risk of emergence of bacterial resistance through the transmission of genetic material are not completely solved problems. Further studies specifically devoted to solve these problems are needed before BPs can be used in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ecology of prokaryotic viruses
Weinbauer, M. G. (2004) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2003.08.001 · Cited by 1,771
Rodriguez-Mozaz, S., Chamorro, S., Marti, E., Huerta, B., Gros, M., Sànchez-Melsió, A., Borrego, C. M., Barceló, D., & Balcázar, J. L. (2015) · Water Research · doi:10.1016/j.watres.2014.11.021 · Cited by 1,623
Clokie, M. R. J., Millard, A. D., Letarov, A. V., & Heaphy, S. (2011) · Bacteriophage · doi:10.4161/bact.1.1.14942 · Cited by 1,149
Phage treatment of human infections
Abedon, S. T., Kuhl, S. J., Blasdel, B. G., & Kutter, E. M. (2011) · Bacteriophage · doi:10.4161/bact.1.2.15845 · Cited by 980
Dispersing biofilms with engineered enzymatic bacteriophage
Lu, T. K., & Collins, J. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704624104 · Cited by 895
Jault, P., Leclerc, T., Jennes, S., Pirnay, J. P., Que, Y.-A., Resch, G., Rousseau, A. F., Ravat, F., Carsin, H., Le Floch, R., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30482-1 · Cited by 874
Wright, A., Hawkins, C. H., Änggård, E. E., & Harper, D. R. (2009) · Clinical Otolaryngology · doi:10.1111/j.1749-4486.2009.01973.x · Cited by 864
A century of the phage: past, present and future
Salmond, G. P. C., & Fineran, P. C. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3564 · Cited by 823
Sarker, S. A., Sultana, S., Reuteler, G., Moine, D., Descombes, P., Charton, F., Bourdin, G., McCallin, S., Ngom-Bru, C., Neville, T., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2015.12.023 · Cited by 533
Smith, H. W., & Huggins, M. B. (1982) · Microbiology · doi:10.1099/00221287-128-2-307 · Cited by 518
Rosenquist, H., Nielsen, N. L., Sommer, H. M., Nørrung, B., & Christensen, B. B. (2003) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(02)00317-3 · Cited by 503
Bacteriophages as potential new therapeutics to replace or supplement antibiotics
Kutateladze, M., & Adamia, R. (2010) · Trends in Biotechnology · doi:10.1016/j.tibtech.2010.08.001 · Cited by 483
Summers, W. C. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.437 · Cited by 474
Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial
Rhoads, D. D., Wolcott, R. D., Kuskowski, M. A., Wolcott, B. M., Ward, L. S., & Sulakvelidze, A. (2009) · Journal of Wound Care · doi:10.12968/jowc.2009.18.6.42801 · Cited by 468
Phages rarely encode antibiotic resistance genes: a cautionary tale for virome analyses
Enault, F., Briet, A., Bouteille, L., Roux, S., Sullivan, M. B., & Petit, M.-A. (2017) · The ISME Journal · doi:10.1038/ismej.2016.90 · Cited by 441
Smith, H. W., & Huggins, M. B. (1983) · Microbiology · doi:10.1099/00221287-129-8-2659 · Cited by 436
Phage Therapy—History from Twort and d'Herelle Through Soviet Experience to Current Approaches
Chanishvili, N. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00001-3 · Cited by 407
Bacteriophage Therapy To Reduce Campylobacter jejuni Colonization of Broiler Chickens
Loc Carrillo, C., Atterbury, R. J., El-Shibiny, A., Connerton, P. L., Dillon, E., Scott, A., & Connerton, I. F. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.11.6554-6563.2005 · Cited by 367
The Control of Experimental Escherichia coli Diarrhoea in Calves by Means of Bacteriophages
Smith, H. W., Huggins, M. B., & Shaw, K. M. (1987) · Microbiology · doi:10.1099/00221287-133-5-1111 · Cited by 365
Reverse Transcriptase-Mediated Tropism Switching in Bordetella Bacteriophage
Liu, M., Deora, R., Doulatov, S. R., Gingery, M., Eiserling, F. A., Preston, A., Maskell, D. J., Simons, R. W., Cotter, P. A., Parkhill, J., et al. (2002) · Science · doi:10.1126/science.1067467 · Cited by 288
Morello, E., Saussereau, E., Maura, D., Huerre, M., Touqui, L., & Debarbieux, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016963 · Cited by 275
McCallin, S., Alam Sarker, S., Barretto, C., Sultana, S., Berger, B., Huq, S., Krause, L., Bibiloni, R., Schmitt, B., Reuteler, G., et al. (2013) · Virology · doi:10.1016/j.virol.2013.05.022 · Cited by 265
Drulis-Kawa, Z., Majkowska-Skrobek, G., Maciejewska, B., Delattre, A.-S., & Lavigne, R. (2012) · Current Protein & Peptide Science · doi:10.2174/138920312804871193 · Cited by 261
Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review
Kakasis, A., & Panitsa, G. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.09.004 · Cited by 261
Phage therapy experience at the Eliava Institute
Kutateladze, M., & Adamia, R. (2008) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2008.06.023 · Cited by 258
Battling Phages: How Bacteria Defend against Viral Attack
Seed, K. D. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004847 · Cited by 245
Markoishvili, K., Tsitlanadze, G., Katsarava, R., Glenn, J., Morris Jr., M. D., & Sulakvelidze, A. (2002) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2002.01451.x · Cited by 243
Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh
Sarker, S. A., McCallin, S., Barretto, C., Berger, B., Pittet, A.-C., Sultana, S., Krause, L., Huq, S., Bibiloni, R., Bruttin, A., et al. (2012) · Virology · doi:10.1016/j.virol.2012.09.002 · Cited by 240
Chibani-Chennoufi, S., Sidoti, J., Bruttin, A., Kutter, E., Sarker, S., & Brüssow, H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2558-2569.2004 · Cited by 234
Alemayehu, D., Casey, P. G., McAuliffe, O., Guinane, C. M., Martin, J. G., Shanahan, F., Coffey, A., Ross, R. P., & Hill, C. (2012) · mBio · doi:10.1128/mbio.00029-12 · Cited by 231
Carvalho, C. M., Gannon, B. W., Halfhide, D. E., Santos, S. B., Hayes, C. M., Roe, J. M., & Azeredo, J. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-232 · Cited by 223
Bacteriophage treatment of intransigent diabetic toe ulcers: a case series
Fish, R., Kutter, E., Wheat, G., Blasdel, B., Kutateladze, M., & Kuhl, S. (2016) · Journal of Wound Care · doi:10.12968/jowc.2016.25.7.s27 · Cited by 222
Treatment of experimental infections of mice with bacteriophages
SOOTHILL, J. S. (1992) · Journal of Medical Microbiology · doi:10.1099/00222615-37-4-258 · Cited by 220
Reversing Bacterial Resistance to Antibiotics by Phage-Mediated Delivery of Dominant Sensitive Genes
Edgar, R., Friedman, N., Molshanski-Mor, S., & Qimron, U. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.05741-11 · Cited by 217
Experimental phage therapy of burn wound infection: difficult first steps.
Rose, T., Verbeken, G., Vos, D. D., Merabishvili, M., Vaneechoutte, M., Lavigne, R., Jennes, S., Zizi, M., & Pirnay, J. (2014) · PubMed · Cited by 213
Rohde, C., Resch, G., Pirnay, J.-P., Blasdel, B., Debarbieux, L., Gelman, D., Górski, A., Hazan, R., Huys, I., Kakabadze, E., et al. (2018) · Viruses · doi:10.3390/v10040178 · Cited by 210
Bacteriophages: Protagonists of a Post-Antibiotic Era
Domingo-Calap, P., & Delgado-Martínez, J. (2018) · Antibiotics · doi:10.3390/antibiotics7030066 · Cited by 209
Smith, H. W., Huggins, M. B., & Shaw, K. M. (1987) · Microbiology · doi:10.1099/00221287-133-5-1127 · Cited by 202
The disparate effects of bacteriophages on antibiotic-resistant bacteria
Torres-Barceló, C. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0169-z · Cited by 189
Immunogenicity Studies of Proteins Forming the T4 Phage Head Surface
Dąbrowska, K., Miernikiewicz, P., Piotrowicz, A., Hodyra, K., Owczarek, B., Lecion, D., Kaźmierczak, Z., Letarov, A., & Górski, A. (2014) · Journal of Virology · doi:10.1128/jvi.02043-14 · Cited by 185
Hawkins, C., Harper, D., Burch, D., Änggård, E., & Soothill, J. (2010) · Veterinary Microbiology · doi:10.1016/j.vetmic.2010.05.014 · Cited by 183
Bacteriophage Therapy: Advances in Formulation Strategies and Human Clinical Trials
Vandenheuvel, D., Lavigne, R., & Brüssow, H. (2015) · Annual Review of Virology · doi:10.1146/annurev-virology-100114-054915 · Cited by 176
On-Demand Isolation of Bacteriophages Against Drug-Resistant Bacteria for Personalized Phage Therapy
Mattila, S., Ruotsalainen, P., & Jalasvuori, M. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01271 · Cited by 165
Seed, K. D., Faruque, S. M., Mekalanos, J. J., Calderwood, S. B., Qadri, F., & Camilli, A. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002917 · Cited by 159
Metagenomic analysis reveals that bacteriophages are reservoirs of antibiotic resistance genes
Subirats, J., Sànchez-Melsió, A., Borrego, C., Balcázar, J. L., & Simonet, P. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.04.028 · Cited by 158
Bourdin, G., Schmitt, B., Marvin, L., Germond, J., Zuber, S., Michot, L., Reuteler, G., & Brüssow, H. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.03357-13 · Cited by 157
Efficacy of Bacteriophage Therapy in a Model ofBurkholderia cenocepaciaPulmonary Infection
Carmody, L. A., Gill, J. J., Summer, E. J., Sajjan, U. S., Gonzalez, C. F., Young, R., & LiPuma, J. J. (2009) · The Journal of Infectious Diseases · doi:10.1086/649227 · Cited by 154
Stability of Staphylococcus aureus Phage ISP after Freeze-Drying (Lyophilization)
Merabishvili, M., Vervaet, C., Pirnay, J., Vos, D. D., Verbeken, G., Mast, J., Чанішвілі, Н., & Vaneechoutte, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068797 · Cited by 150
Antibiotic Resistance Genes in the Bacteriophage DNA Fraction of Human Fecal Samples
Quirós, P., Colomer-Lluch, M., Martínez‐Castillo, A., Miró, E., Argente, M., Jofre, J. T., Navarro, F., & Muniesa, M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01684-13 · Cited by 147
Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa
Soothill, J. S. (1994) · Burns · doi:10.1016/0305-4179(94)90184-8 · Cited by 145
Pouillot, F., Chomton, M., Blois, H., Courroux, C., Noelig, J., Bidet, P., Bingen, É., & Bonacorsi, S. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06330-11 · Cited by 145
Parsley, L. C., Consuegra, E. J., Kakirde, K. S., Land, A. M., Harper, W. F., & Liles, M. R. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.03080-09 · Cited by 145
Hoyle, N. S., Zhvania, P., Balarjishvili, N., Bolkvadze, D., Nadareishvili, L., Nizharadze, D., Wittmann, J., Rohde, C., & Kutateladze, M. (2018) · Research in Microbiology · doi:10.1016/j.resmic.2018.05.001 · Cited by 145
Marti, E., Variatza, E., & Balcázar, J. L. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12446 · Cited by 133
Evolution of Foodborne Pathogens via Temperate Bacteriophage-Mediated Gene Transfer
Brabban, A. D., Hite, E., & Callaway, T. R. (2005) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2005.2.287 · Cited by 131
Colomer-Lluch, M., Jofre, J. T., & Muniesa, M. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt528 · Cited by 119
Applications of Bacteriophages in the Treatment of Localized Infections in Humans
Витальевна, М. В., Vlassov, V. V., & Викторовна, Т. Н. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01696 · Cited by 117
Phage Therapy Faces Evolutionary Challenges
Barceló, C. T. (2018) · Viruses · doi:10.3390/v10060323 · Cited by 116
Role of Staphylococcal Phage and SaPI Integrase in Intra- and Interspecies SaPI Transfer
Maiques, E., Úbeda, C., Tormo‐Más, M. Á., Ferrer, M. D., Lasa, Í., Novick, R. P., & Penadés, J. R. (2007) · Journal of Bacteriology · doi:10.1128/jb.00619-07 · Cited by 115
T4 Phage and Its Head Surface Proteins Do Not Stimulate Inflammatory Mediator Production
Miernikiewicz, P., Dąbrowska, K., Piotrowicz, A., Owczarek, B., Wojas-Turek, J., Kicielińska, J., Rossowska, J., Pajtasz‐Piasecka, E., Hodyra‐Stefaniak, K., Macegoniuk, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071036 · Cited by 115
Evidence that TraT interacts with OmpA of Escherichia coli
Riede, I., & Eschbach, M.-L. (1986) · FEBS Letters · doi:10.1016/0014-5793(86)80905-x · Cited by 101
Singla, S., Harjai, K., Katare, O. P., & Chhibber, S. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv029 · Cited by 96
Fancello, L., Desnues, C., Raoult, D., & Rolain, J. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr315 · Cited by 91
Fish, R., Kutter, E. M., Wheat, G., Blasdel, B. G., Kutateladze, M., & Kuhl, S. J. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7395-8_14 · Cited by 91
Virus species and virus identification: Past and current controversies
Regenmortel, M. H. V. V. (2006) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2006.04.002 · Cited by 87
O’Shea, Y. A., & Boyd, E. F. (2002) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2002.tb11339.x · Cited by 83
Effect of Protein A on Adsorption of Bacteriophages to Staphylococcus aureus
Nordström, K., & Forsgren, A. (1974) · Journal of Virology · doi:10.1128/jvi.14.2.198-202.1974 · Cited by 82
Comparison of Several Methods for Preserving Bacteriophages
Clark, W. A. (1962) · Applied Microbiology · doi:10.1128/am.10.5.466-471.1962 · Cited by 81
Bacteriophages as vehicles of the resistome in cystic fibrosis
Rolain, J., Fancello, L., Desnues, C., & Raoult, D. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr318 · Cited by 78
Marti, E., Huerta, B., Rodríguez‐Mozaz, S., Barceló, ., Marcé, R., & Balcázar, J. L. (2017) · Chemosphere · doi:10.1016/j.chemosphere.2017.12.108 · Cited by 76
Immunological factors that affect the in vivo fate of T7 phage in the mouse
Srivastava, A., Kaido, T., & Carrier, E. (2003) · Journal of Virological Methods · doi:10.1016/j.jviromet.2003.09.009 · Cited by 72
Effectiveness of bacteriophages in the sputum of cystic fibrosis patients
Saussereau, E., Vachier, I., Chiron, R., Godbert, B., Sermet‐Gaudelus, I., Dufour, N., Pirnay, J., Vos, D. D., Carrié, F., Molinari, N., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12712 · Cited by 68
Observation of inflammatory responses in mice orally fed with bacteriophage T7
Park, K., Cha, K., & Myung, H. (2014) · Journal of Applied Microbiology · doi:10.1111/jam.12565 · Cited by 64
A sustainable model for antibiotics
Perros, M. (2015) · Science · doi:10.1126/science.aaa3048 · Cited by 51
Bacteriophage Treatment of Infected Diabetic Foot Ulcers
Витальевна, М. В., Kozlova, Y. N., Ganichev, D. A., & Викторовна, Т. Н. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7395-8_13 · Cited by 51
Molecular imaging of T4 phage in mammalian tissues and cells
Kaźmierczak, Z., Piotrowicz, A., Owczarek, B., Hodyra‐Stefaniak, K., Miernikiewicz, P., Lecion, D., Harhala, M. A., Górski, A., & Dąbrowska, K. (2014) · Bacteriophage · doi:10.4161/bact.28364 · Cited by 45
Hwang, J.-Y., Kim, J., Song, Y., & Park, J. (2016) · Food Science and Biotechnology · doi:10.1007/s10068-016-0050-6 · Cited by 12
Cited by
Understanding bacterial biofilms: From definition to treatment strategies
Zhao, A., Sun, J., & Liu, Y. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1137947 · Cited by 743
Advances in Antimicrobial Microneedle Patches for Combating Infections
Jamaledin, R., Yiu, C. K. Y., Zare, E. N., Niu, L., Vecchione, R., Chen, G., Gu, Z., Tay, F. R., & Makvandi, P. (2020) · Advanced Materials · doi:10.1002/adma.202002129 · Cited by 461
Combating Implant Infections: Shifting Focus from Bacteria to Host
Amin Yavari, S., Castenmiller, S. M., van Strijp, J. A. G., & Croes, M. (2020) · Advanced Materials · doi:10.1002/adma.202002962 · Cited by 257
Genetically Engineered Microorganisms and Their Impact on Human Health
Mahdizade Ari, M., Dadgar, L., Elahi, Z., Ghanavati, R., & Taheri, B. (2024) · International Journal of Clinical Practice · doi:10.1155/2024/6638269 · Cited by 67
Bacteriophage Therapy: Discovery, Development, and FDA Approval Pathways
Niazi, S. K. (2025) · Pharmaceuticals · doi:10.3390/ph18081115 · Cited by 56
Metadata
- Authors
- Principi, N., Silvestri, E., & Esposito, S.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2019-05-08
- Volume
- 10
- Pages
- 513-513
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2944502015
- Cited by
- 454
- References
- 77
- FWCI
- 29.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.